Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT03649035
Eligibility Criteria:
Inclusion criteria:
* Only patients with pathologically proven, locally advanced, unresectable pancreatic adenocarcinoma will be selected.
* The criteria for unresectability will be: encasement or thrombosis of one or more large vessels surrounding the pancreas (celiac axis, portal vein, and/or superior mesenteric artery and/or vein, and/or hepatic artery, except the splenic vessels); infiltration of the vessel wall or contact 180° for more than 2 cm length, with initial stricture of the vessel or alteration of the Doppler signal (each patient will undergo thoracic and abdominal-CT with contrast medium to check resectability and detect the absence of distant metastasis).
Esclusion criteria:
* Patients with pancreatic tumors other than pancreatic adenocarcinoma (PDAC)
* Patients with resectable, borderline resectable or metastatic PDAC
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03649035
Study Brief:
Protocol Section:
NCT03649035